| Literature DB >> 31693671 |
Madhu Gupta1, Madhur Verma1, Kiranjit Kaur1, Kirti Iyengar2, Tarundeep Singh1, Anju Singh3.
Abstract
OBJECTIVES: The objectives of the study were to assess the knowledge and skills of medical interns and nurses regarding family planning (FP) services, and document the prevailing FP practices in the teaching hospitals in India. STUDYEntities:
Mesh:
Substances:
Year: 2019 PMID: 31693671 PMCID: PMC6834278 DOI: 10.1371/journal.pone.0211168
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Knowledge of interns and nurses regarding reversible long–acting contraceptives (intrauterine contraceptive devices and hormonal contraceptives, post–partum contraception) and permanent contraceptives (tubectomy).
| Parameters | Interns | Nurses | Total | P value |
|---|---|---|---|---|
| • Copper containing IUCDs | 81 (100; 100–100) | 78 (95.1; 92.7–97.5) | 159 (97.6; 96.4–98.8) | 0.000 |
| • Hormonal IUCDs | 60 (74.1; 69.2–79.0) | 12 (14.6; 10.7–18.5) | 72 (44.2; 40.4–48.2) | |
| • First generation /inert IUCDs | 51 (63.0; 57.6–68.4) | 23 (28.1; 23.1–33.1) | 74 (45.4; 41.5–49.3) | |
| • 10 Years | 42 (51.9; 46.3–57.5) | 29 (35.4; 30.1–40.7) | 71 (43.6; 39.7–47.5) | 0.034 |
| • Pregnancy | 46 (56.8; 51.3–62.3) | 40 (48.8;43.3–54.3) | 86 (52.8; 48.9–56.7) | 0.287 |
| • STI/HIV | 53 (65.4; 60.1–70.7) | 36 (43.9; 38.4–49.4) | 89 (54.6; 50.7–58.5) | |
| • Irregular Periods | 50 (61.7; 56.3–67.1) | 54 (65.9; 60.7–71.1) | 104 (63.8; 60.0–67.6) | |
| • Adnexal Mass/Ectopic Pregnancy | 41(50.6; 45.0–56.2) | 25 (30.5; 25.4–35.6) | 66 (40.5; 36.7–44.3) | |
| • Multiple Sexual Partners | 1 (1.2; 0.0–2.4) | 0 | 1 (0.6; 0.0–1.2) | |
| • Pain/cramps | 61 (75.3; 70.5–80.1) | 55 (67.9; 62.7–73.1) | 116 (71.6; 68.1–75.1) | 0.004 |
| • Bleeding/menorrhagia/spotting/irregular bleeding | 61 (75.3; 70.5–80.1) | 72 (88.9; 85.4–92.4) | 133 (82.1; 79.1–85.1) | |
| • Infections/PID/vaginal discharge | 51 (63.0; 57.6–68.4) | 32 (39.5; 34.1–44.9) | 83 (51.2; 47.3–55.1) | |
| • Expulsion | 29 (34.6; 29.3–39.9) | 9 (11.1; 8.6–15.8) | 37 (22.8; 19.5–26.1) | |
| • Within 10 minutes of delivery | 37 (45.7; 40.2–51.2) | 30 (36.4; 31.1–41.7) | 67 (41.1; 37.2–45.0) | 0.001 |
| • Within 48 hours | 27 (33.3; 28.1–38.5) | 10 (12.2; 8.6–15.8) | 37 (22.7; 19.4–26.0) | |
| • During caesarean section | 10 (12.4; 8.7–16.1) | 8 (9.8; 6.5–13.1) | 18 (11.0; 8.5–13.5) | |
| • Other | 26 (32.1; 26.8–37.2) | 11 (13.4; 9.6–17.2) | 37 (22.7; 19.4–26.0) | |
| • Don’t know | 2 (2.5; 0.8–4.2) | 13 (16.0; 12.0–20.0) | 15 (9.3; 7.0–11.6) | |
| • Ante-natal period | 40 (49.4; 43.8–55.0) | 29 (35.8; 30.5–41.1) | 69 (42.3; 38.4–46.2) | 0.001 |
| • Inta-natal period | 31 (38.3; 32.9–43.7) | 16 (19.5; 15.1–23.9) | 45 (28.8; 25.3–32.3) | |
| • Post-natal period | 8 (9.9; 6.6–13.2) | 25 (30.9; 25.8–36.0) | 33 (20.4; 17.2–23.6) | |
| • Pregnancy | 14 (17.3;13.1–21.5) | 12 (14.8; 10.9–18.7) | 26 (16.0; 13.1–18.9) | 0.639 |
| • Irregular periods | 24 (29.6; 24.5–34.7) | 15 (18.5; 14.2–22.8) | 39 (24.7; 21.3–28.1) | |
| • Breast cancer | 20 (24.7; 19.9–29.5) | 12 (14.9; 11.0–18.8) | 32 (19.8; 16.7–22.9) | |
| • Liver diseases | 9 (11.1; 7.6–14.6) | 5 (6.2; 3.5–8.9) | 14 (8.6; 6.4–10.8) | |
| • Thromboembolic episodes | 11 (13.6; 9.8–17.4) | 7 (8.6; 5.5–11.7) | 18 (11.1; 8.6–13.6) | |
| • Menstruation related side effects | 27 (33.3; 28.1–38.5) | 14 (17.2; 13.0–21.4) | 41 (25.2; 21.8–28.6) | 0.668 |
| • Delayed return of fertility | 14 (17.3; 13.1–21.5) | 5 (6.1; 3.5–8.7) | 19 (11.6; 9.1–14.1) | |
| • Don’t know | 19 (23.7; 19.0–28.4) | 12 (15.0; 11.1–18.9) | 31 (19.4; 16.3–22.5) | |
| • Intrauterine contraceptive device | 45 (55.6; 50.1–61.1) | 61 (74.4; 69.6–79.2) | 106 (65.0; 61.3–68.7) | 0.000 |
| • Injectable contraceptives | 8 (9.9; 6.6–13.2) | 9 (11.0; 7.5–14.5) | 17 (10.4; 8.0–12.8) | |
| • Progesterone only Pills | 31 (38.3; 32.9–43.7) | 6 (7.3;4.4–10.2) | 37 (22.7; 19.4–26.0) | |
| • Condoms | 56 (69.1; 64.0–74.2) | 54 (65.9; 60.7–71.1) | 110 (67.9; 64.2–71.6) | |
| • Eligibility checklist for Tubectomy | 12 (85.2; 81.3–89.1) | 14 (79.3; 74.8–83.8) | 26 (82.2; 79.2–85.2) | 0.259 |
| • Tubectomy operation | 31 (38.3; 32.9–43.7) | 39 (47.6; 42.1–53.1) | 70 (43.0; 39.1–46.9) | |
| • Consent form for Tubectomy | 24 (29.6; 24.5–34.7) | 50 (61.0; 55.6–66.4) | 74 (45.4; 41.5–49.3) | |
| • Amenorrhoea | 18 (22.2; 17.6–26.8) | 14 (83.0; 78.9–87.1) | 32 (80.4; 77.3–83.5) | 0.024 |
| • Exclusive breast feeding | 59 (72.8; 67.9–77.7) | 45 (54.9; 49.4–60.4) | 104 (63.8; 60.0–67.6) | |
| • 6 months post-partum | 43 (53.1; 47.6–58.6) | 36 (43.9; 38.4–49.4) | 79 (48.5; 44.6–52.4) | |
| • All | 15 (18.5; 10.8–28.7) | 11 (13.4; 6.9–22.7) | 26 (16.0; 10.7–22.5) | |
| • Don’t know | 11 (13.8; 10.0–17.6) | 27 (33.3; 1.3–5.3) | 38 (23.6; 20.3–26.9) |
p value indicates the statistical significant difference in the proportion of interns and nurses regarding their knowledge.
Background characteristics of study participants.
| Characteristics | Interns | Nurses | Total | P value |
|---|---|---|---|---|
| Male | 41 (50.6; 45.0–56.2) | 13 (15.8;12.2–19.4) | 54 (33.1;29.4–36.8) | 0.593 |
| Female | 40 (49.3; 43.7–54.9) | 69 (84.1; 78.3–89.9) | 109 (66.8;63.1–70.5) | |
| 23.8(1.2) | 29.2(3.3) | 26.4(3.7) | ||
| 20–24 | 66 (81.5; 77.2–85.8) | 4 (4.9; 3.1–6.7) | 70 (42.9;39.0–46.8) | 0.000 |
| 24–29 | 15(18.5; 14.2–22.8) | 45 (54.9; 48.4–61.4) | 60(36.8;33.0–46.8) | |
| 30–34 | 0 | 30 (36.6; 30.6–42.6) | 30(18.4;15.4–21.4) | |
| > = 35 | 0 | 3 (3.6; 1.5–5.7) | 3(1.8;0.8–2.8) | |
| < = 1 year | 81 (100; 100–100) | 2 (2.4; 1.2–3.6) | 83(50.9;47.0–54.8) | 0.000 |
| 2 years | 0 | 22 (26.8;21.5–32.1) | 22(13.5;10.8–16.2) | |
| 3 years | 0 | 16 (19.5;14.9–24.1) | 16(9.8;7.5–12.1) | |
| 4 years | 0 | 24 (29.3;23.8–34.8) | 24(14.7;11.9–17.5) | |
| > = 5 years | 0 | 18 (22.0;17.1–26.9) | 18(11.0;8.5–13.5) | |
| Married | 7 (8.6;5.5–11.7) | 70 (85.4) | 77 (47.2;43.3–51.1) | 0.000 |
| Unmarried | 74 (91.4;88.3–94.5) | 12 (14.6) | 86 (52.8;48.9–56.7) | |
| 19 (23.5;18.8–28.2) | 0 | 19 (11.7;9.2–14.2) | ||
| MC 2 | 16 (19.8; 15.4–24.2) | 16 (19.8; 15.4–24.2) | 32 (19.6;16.5–22.7) | |
| MC 3 | 15 (18.5;14.2–22.8) | 16 (19.8;15.4–24.2) | 31 (19.0;15.9–22.1) | |
| MC 4 | 11 (13.6;9.8–17.4) | 19 (23.5;18.8–28.2) | 30 (18.4;15.4–21.4) | |
| MC 5 | 17 (21.0;16.5–25.5) | 23 (28.4;23.4–33.4) | 40 (24.5;21.1–27.9) | |
| MC 6 | 3 (3.7;1.6–5.8) | 8(9.9; 6.6–13.2) | 11 (6.7;4.7–8.7) |
* MC: Medical College; p value indicate the statistical significant difference in the proportion of interns and nurses
Knowledge of interns and nurses regarding various contraceptive methods and reproductive rights of the clients.
| Parameters | Interns | Nurses | Total | p-value |
|---|---|---|---|---|
| • Condom | 74 (91.3; 88.2–94.4) | 70 (85.3; 81.4–89.2) | 144 (88.3; 85.8–90.8) | 0.992 |
| • OCP | 68 (83.9; 79.8–88.0) | 59 (71.9; 66.9–76.9) | 127 (77.9; 74.7–81.1) | |
| • POP | 6 (7.3; 4.4–10.2) | 6 (7.4;4.5–10.3) | 11 (6.8;4.8–8.8) | |
| • IUCD | 30 (36.5; 31.2–41.8) | 30 (36.5; 31.2–41.8) | 60 (36.8;33.0–40.6) | |
| • All | 1 (1.2; 0–2.4) | 1 (1.2; 0.0–2.4) | 2 (1.2;0.3–2.1) | |
| • Condom | 38 (46.9; 41.4–52.3) | 44 (53.7; 48.2–59.2) | 82 (50.3; 46.4–54.2) | 0.460 |
| • OCP | 44 (54.3; 48.8–59.8) | 47 (57.3; 51.8–62.8) | 91 (55.8;51.9–59.7) | |
| • POP | 3 (3.7; 1.6–5.8) | 9 (11.0; 7.5–14.5) | 12 (7.4;5.3–9.5) | |
| • IUCD | 75 (92.6; 89.7–95.5) | 77 (93.9; 91.3–96.5) | 152 (93.4;91.5–95.3) | |
| • All | 0 | 1 (1.2;0.0–2.4) | 1 (0.6; 0.0–1.2) | |
| • Condom | 16 (19.8; 15.4–24.2) | 21 (25.6;20.8–30.4) | 37 (22.7; 19.4–26.0) | 0.907 |
| • OCP | 15 (18.5; 14.2–22.8) | 13 (15.8; 11.8–19.8) | 28 (17.2; 14.2–20.2) | |
| • POP | 1 (1.2; 0.0–2.4) | 2 (2.4; 0.7–4.1) | 3 (1.8; 0.8–2.8) | |
| • IUCD | 48 (59.3; 53.8–64.8) | 50 (61.0; 55.6–66.4) | 98 (60.1; 56.3–63.9) | |
| • Sterilization | 77 (95.1; 92.7–97.5) | 79 (96.3; 94.2–98.4) | 156 (95.8; 94.2–97.4) | |
| • Yes | 64 (79.0; 74.5–83.4) | 35 (43.2; 37.7–48.7) | 99 (61.1; 57.3–64.9) | 0.000 |
| • Yes, but after asking the family members | 8 (4.9;2.5–7.3) | 19 (11.7; 8.2–15.2) | 27 (16.7; 13.8–19.6) | |
| • No | 9 (11.1;7.6–14.6) | 27 (33.3; 28.1–38.5) | 36 (22.2;18.9–25.5) | |
| • Yes | 60 (37.0; 31.6–42.4) | 29 (17.9;13.7–22.1) | 89 (54.9; 51.0–58.8) | 0.000 |
| • Yes but after asking the family members | 7 (8.6;5.5–11.7) | 11 (13.6; 9.8–17.4) | 18 (11.1;8.6–13.6) | |
| • No | 10 (12.4;8.7–16.1) | 42 (51.9; 46.4–57.4) | 52 (32.1; 28.4–35.8) | |
| • Yes | 52 (64.2; 58.9–69.5) | 33 (40.2; 34.8–45.6) | 85 (52.1; 48.2–56.0) | 0.000 |
| • No | 14 (17.3; 13.1–21.5) | 38 (46.3;40.8–51.8) | 52 (31.9; 28.2–35.6) | |
| • Don’t know | 15 (18.5;14.2–22.8) | 11 (13.4; 9.6–17.2) | 26 (16;13.1–18.9) |
*OCP: Oral Contraceptive Pill; POP: Progesterone Pills; IUCD: Intrauterine contraceptive devices; p value indicates the statistical significant difference in the proportion of interns and nurses regarding their knowledge.
Knowledge of interns and nurses regarding oral contraceptive pills, condoms, and emergency contraceptives.
| Contraceptives | Interns | Nurses | Total | p-value |
|---|---|---|---|---|
| • Smoking | 10 (12.4; 8.7–16.1) | 5 (6.1; 3.5–8.7) | 15 (9.2; 6.9–11.5) | 0.060 |
| • Diabetes | 10 (12.4;8.7–16.1) | 15 (18.3; 14.0–22.6) | 25 (15.3; 12.5–18.1) | |
| • Headaches | 24 (29.6; 24.5–34.7) | 18 (21.95; 17.3–26.5) | 42 (25.7; 22.3–29.1) | |
| • Cardiovascular diseases | 45 (55.6; 50.1–61.1) | 23 (28.1; 23.1–33.1) | 68 (41.7; 37.8–45.6) | |
| • Thromboembolic disorders | 29 (35.8; 30.5–41.1) | 7 (8.5;5.4–11.6) | 36 (22.1; 18.9–25.3) | |
| • Post-partum haemorrhage | 7 (8.6; 5.5–11.7) | 2 (2.4; 0.7–4.1) | 9 (5.5; 3.7–7.3) | |
| • liver disease | 28 (34.6; 29.3–39.9) | 11 (13.4;9.6–17.2) | 39 (24.0; 20.7–27.3) | |
| • Breast disease | 33 (40.7; 35.2–46.2) | 16 (19.8; 15.4–24.2) | 49 (30.6; 27.0–34.2) | |
| • When to start OCP | 64 (79.0;74.5–83.5) | 62 (76.6; 71.9–81.3) | 126 (77.8; 74.5–81.1) | 0.471 |
| • Daily intake without fail | 71 (87.7;84.1–91.3) | 67 (82.7; 78.5–86.9) | 138 (85.2; 82.4–88.0) | |
| • What to do if misses a pill | 56 (69.5; 64.4–74.6) | 41 (50.6; 45.1–56.1) | 97 (59.9;56.1–63.7) | |
| • Possible side effects | 22 (27.5;22.5–32.5) | 13 (16.1; 12.0–20.2) | 35 (21.6; 18.4–24.8) | |
| • To take 2 pills the next day | 42 (51.9; 46.3–57.5) | 43 (53.1; 47.6–58.6) | 85 (52.8; 48.9–56.7) | 0.025 |
| • Again 2 pills the second next day | 16 (19.8; 15.4–24.2) | 12 (14.9; 11.0–18.8) | 28 (17.3; 18.4–24.8) | |
| • The couple should also use condom for 7 days | 34 (42.0; 36.5–47.5) | 12 (14.9; 11.0–18.8) | 46 (24.4; 21.0–27.8) | |
| • Newly married women | 68 (84.0; 79.9–88.1) | 43 (52.5; 47.0–58.0) | 111 (68.1; 64.4–71.8) | 0.079 |
| • Illiterate women | 64 (79.0; 74.5–83.5) | 60 (73.2; 68.3–78.1) | 124 (76.1; 72.8–73.6) | |
| • Women who do not want any more children | 53 (65.4; 60.1–70.7) | 61 (74.4; 69.6–79.2) | 114 (70.0; 66.4–73.6) | |
| • Condoms | ||||
| • <5% | 34 (2.0; 0.4–3.6) | 17 (21.0; 16.5–25.5) | 51 (31.5; 27.9–35.1) | 0.002 |
| • 6–15% | 35 (43.2; 37.7–48.7) | 20 (24.7; 19.9–29.5) | 55 (34.0; 30.3–37.7) | |
| • >15% | 4 (5.0; 2.6–7.4) | 5 (6.2; 3.5–8.9) | 9 (5.6; 3.8–7.4) | |
| • Other | 1 (1.2; 0.0–2.4) | 6 (7.4; 4.5–10.3) | 7 (4.3; 2.7–5.9) | |
| • Do not know | 3 (3.7; 1.6–5.8) | 12 (14.8; 10.9–18.7) | 15 (9.3; 7.0–11.6) | |
| • Dual protection against pregnancy and STI/HIV | 70 (86.4; 91.1–96.5) | 47 (58.0; 52.5–63.5) | 117 (72.2; 68.7–75.7) | 0.016 |
| • No side effects | 23 (28.4;23.4–33.4) | 34 (42.0; 36.5–47.5) | 56 (35.2; 31.5–38.9) | |
| • Emergency contraceptive pills | 76 (93.8;91.1–96.5) | 71 (86.6; 82.8–90.4) | 147 (90.2; 87.9–92.5) | 0.000 |
| • Intrauterine contraceptive devices | 45 (55.6; 50.1–61.1) | 6 (7.3; 4.4–10.2) | 51 (31.3; 27.7–34.9) | |
| • Yuzpe’s method | 24 (29.6; 24.5–34.7) | 4 (4.9; 2.5–7.3) | 28 (17.2; 14.2–20.2) | |
| • 24 hours of unprotected intercourse | 0 | 2 (2.4; 0.7–4.1) | 2 (1.2; 0.3–2.1) | 0.177 |
| • 48 hours of unprotected intercourse | 3 (3.7; 1.6–5.8) | 6 (7.32; 4.4–10.2) | 9 (5.5; 3.7–7.3) | |
| • 72 hours of unprotected intercourse | 77 (95.1; 92.7–97.5) | 68 (82.9; 78.7–87.1) | 145 (89.0; 86.5–91.5) | |
| • 1 tablet weekly | 18 (22.2; 17.6–26.8) | 2 (2.4; 0.7–4.1) | 20 (12.3; 9.7–14.9) | 0.000 |
| • Incorrect response | 15 (18.5; 10.8–28.7) | 0 | 15 (9.2; 5.2–14.7) | |
| • Do not know | 48 (59.3; 53.8–64.8) | 80 (97.6; 95.9–99.3) | 128 (78.5; 75.3–81.7) |
^STI/HIV: Sexually Transmitted Infections/Human Immunodeficiency Virus; p value indicates the statistical significant difference in the proportion of interns and nurses regarding their knowledge.
Overall knowledge of interns and nurses regarding various contraceptive methods.
| Parameters (Choices) | The response of Interns n = 81 (%) | The response of Nurses n = 82 (%) | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Correct | Partially correct | Wrong | Don’t know | Correct | Partially correct | Wrong | Don’t know | ||
| Contraceptive choices for newly married couple (Condom, OCP, POP, IUCD, all, few of these) | 23 (28.3) | 50 (61.7) | 8 (9.8) | 0 | 23 (28.0) | 36 (43.0) | 31 (37.8) | 0 (0) | 0.000 |
| Contraceptive choices for a woman with 1 child (Condom, OCP, POP, IUCD, all, few of these) | 27 (33.3) | 28 (34.5) | 26 (32.1) | 0 | 35 (42.3) | 23 (28) | 23 (28.0) | 1(1.2) | 0.440 |
| Contraceptive choices for the woman with 3 children (Condom, OCP, POP, IUCD, sterilization, all, few of these) | 22 (27.1) | 27 (33.3) | 31 (38.2) | 1 (1.2) | 26 (31.7) | 27 (32.1) | 29 (34.1) | 0 (0) | 0.707 |
| Can contraceptives be given to a married woman coming alone? | 68 (83.9) | 0 | 13 (16.0) | 0 | 37 (45.1) | 0 | 45 (54.8) | 0 (0) | 0.000 |
| Can Contraceptives be given to unmarried women coming alone? | 61 (75.3) | 0 | 18 (22.2) | 2 (2.4) | 32 (39) | 0 | 48 (58.5) | 2 (2.4) | 0.000 |
| Is it legal to provide contraceptives to unmarried people? | 52 (64.1) | 0 | 14 (17.2) | 15 (18.5) | 33 (40.2) | 0 | 38 (46.3) | 11 (13.4) | 0.000 |
| Types of IUCDs available (1st generation, Copper, Hormonal) | 18 (22.2) | 15 (18.5) | 48 (59.3) | 0 | 51 (62.2) | 17 (20.7) | 9 (11.0) | 1 (1.2) | 0.000 |
| Common contraindications for IUCDs (pregnancy, STI/HIV, irregular periods/ adnexal mass, ectopic pregnancy, multiple sexual partners) | 17 (21.0) | 18 (22.0) | 42 (51.9) | 3 (3.7) | 20 (24.4) | 27 (32.9) | 25 (30.5) | 8 (9.8) | 0.035 |
| Common side effects of IUCDs | 12 (14.8) | 31 (38.3) | 36 (44.1) | 1 (1.2) | 11 (13.4) | 38 (46.3) | 26 (32.7) | 5 (6.1) | 0.169 |
| Types of Cu-T in government supply (CuT375, 380A) | 24 (29.6) | 48 (59.3) | 3 (3.7) | 6 (7.4) | 19 (23.2) | 28 (34.1) | 6 (7.3) | 29 (35.4) | 0.000 |
| How long does Cu-T 380A offer protection? | 42 (51.91) | 0 (0) | 34 (42.0) | 5 (6.2) | 29 (35.4) | 0 (0) | 37 (45.1) | 16 (19.5) | 0.016 |
| When is PPIUCD inserted? | 15 (18.5) | 43 (53.1) | 11 (13.6) | 12 (14.8) | 9 (11.0) | 36 (43.9) | 8 (9.8) | 29 (35.4) | 0.022 |
| When is consent for PPIUCD taken? | 61 (75.3) | 0 (0) | 10 (12.3) | 10 (12.3) | 3 (3.7) | 43 (52.4) | 17 (20.7) | 19 (23.2) | 0.000 |
| Medical contraindications for OCPs (Any 4 correct responses) | 21 (25.9) | 0 (0) | 49 (60.5) | 11 (13.6) | 15 (17.3) | 0 (0) | 35 (42.7) | 32 (39.0) | 0.001 |
| Yes OCPs can be bought over the counter | 53 (65.4) | 0 (0) | 24 (29.6) | 4 (4.9) | 52 (62.3) | 0 (0) | 29 (35.4) | 1 (1.2) | 0.321 |
| Instructions were given before starting OCPs | 48 (59.3) | 27 (33.3) | 4 (4.9) | 2 (2.5) | 38 (46.3) | 32 (39.0) | 5 (6.1) | 7 (8.5) | 0.215 |
| Instructions if 2 pills are missed | 10 (12.3) | 29 (35.8) | 20 (24.7) | 22 (27.2) | 4 (4.9) | 25 (30.5) | 22 (26.8) | 31 (37.8) | 0.214 |
| Whom can OCPs be given to? (Newly married women, illiterate women, Women who do not want any more children) | 41 (50.6) | 26 (32.1) | 14 (17.3) | 0 (0) | 31 (37.8) | 28 (34.1) | 22 (26.8) | 1 (1.2) | 0.237 |
| Which OCPs are available in govt. supply (Mala N, Mala D) | 14 (17.3) | 63 (77.8) | 3 (3.7) | 1 (1.2) | 23 (28.0) | 39 (47.6) | 5 (6.1) | 15 (18.3) | 0.000 |
| What kind of contraceptive is DMPA? | 59 (72.8) | 0(0) | 8 (9.9) | 14 (17.3) | 32 (39.0) | 0(0) | 3 (3.7) | 47 (57.3) | 0.000 |
| Medical contraindications for DMPA (Any 3 correct responses out of pregnancy/irregular periods, breast cancer, liver disease, thromboembolic episodes) | 8 (9.9) | 21 (25.9) | 11 (13.6) | 41 (50.6) | 5 (6.1) | 16 (19.5) | 3 (3.7) | 58 (70.0) | 0.031 |
| Common side effects of DMPA (menstruation related side effects, delayed return of fertility) | 9 (11.1) | 22 (27.2) | 4 (4.9) | 46 (56.8) | 4 (4.9) | 12 (14.6) | 2 (2.4) | 64 (78.0) | 0.037 |
| Yes, injectable contraceptives are available in the government supply | 36 (44.4) | 0 | 33 (40.7) | 12 (14.8) | 28 (34.1) | 0 | 28 (34.1) | 26 (31.7) | 0.038 |
| Prerequisites for lactational amenorrhea method | 8 (9.9) | 44 (54.3) | 15 (18.5) | 14 (17.3) | 10 (12.2) | 25 (30.5) | 17 (20.7) | 30 (36.6) | 0.010 |
| Contraceptives that can be given to breastfeeding women (Condoms, POP, IUCD, Injectable) | 14 (17.3) | 45 (55.6) | 16 (19.8) | 6 (7.4) | 14 (17.1) | 35 (42.7) | 26 (31.7) | 7 (8.5) | 0.296 |
*OCP: Oral Contraceptive Device; POP: Progesterone Only Pill; IUCD: Intrauterine Contraceptive Device; DMPA: Depot medroxy progesterone acetate, PPIUCD: Post–Partum Intrauterine Contraceptive Device; STI/HIV: Sexually Transmitted Infections/Human Immunodeficiency Virus;
^ Mala–N is a Low dose OCP with nor–ethisterone acetate and ethinyloestradiol and is available in Government supply, while Mala–D is also Combined OCP with levonorgestrel and ethinyloestradiol and is available at the cost of INR 3 under social marketing; p value indicates the statistical significant difference in the proportion of interns and nurses regarding their knowledge.
Objective structured clinical examination (OSCE) score of interns and nurses.
| Parameters | Interns | Nurses | p-value |
|---|---|---|---|
| • Pass | 57 (70.4; 65.3–75.5) | 22 (26.8; 21.9–31.7) | 0.148 |
| • Fail | 8 (9.9; 6.6–13.2) | 7 (8.5; 5.4–11.6) | |
| • Refused to demonstrate appropriate usage of MEC | 16 (19.8; 15.4–24.2) | 53 (64.6; 59.3–69.9) | |
| • Pass | 36 (44.4; 38.9–49.9) | 10 (12.2; 8.6–15.8) | 0.000 |
| • Fail | 10 (12.3; 8.7–15.9) | 15 (18.3; 14.0–22.6) | |
| • Refused to perform a demonstration of Cu T insertion | 35 (43.2; 37.7–48.7) | 57 (69.5; 64.4–74.6) | |
| • Washes hands and wears gloves | 31 (38.3; 32.9–43.7) | 15 (18.3; 14.0–22.6) | 0.729 |
| • Insert the sterile sound with ‘no touch’ technique | 38 (46.9; 41.4–52.4) | 12 (14.6; 10.7–18.5) | |
| • Load IUCD in its sterile package | 31 (38.2; 32.8–43.6) | 7 (8.6; 5.5–11.7) | |
| • Set the blue depth gauge to the measurement of the uterus | 29 (35.8; 29.9–40.5) | 9 (11.0; 7.5–14.5) | |
| • Carefully insert the loaded IUCD and release it into the uterus | 40 (49.4; 43.8–55.0) | 14 (17.1; 12.9–21.3) | |
| • Take out the plunger | 31 (38.3; 32.9–43.7) | 15 (18.3; 14.0–22.6) | |
| • Partially withdraw the insertion tube till the string are visible | 24 (29.6; 24.5–34.7) | 9 (11.0; 7.5–14.5) | |
| • Use sterile scissors to cut the IUCD strings to 3–4 cm length in the vagina | 20 (24.7; 19.9–29.5) | 11 (13.4; 9.6–17.2) | |
| • Pass | 51 (63.0; 57.6–68.4) | 33 (40.2; 34.8–45.6) | 0.348 |
| • Fail | 15 (18.5; 14.2–22.8) | 12 (14.6; 10.7–18.5) | |
| • Refused to perform demonstration of Condom usage | 15 (18.5; 14.2–22.8) | 37 (45.1; 39.6–50.6) | |
| • Check the expiry date on the wrapper | 1 (1.2; 0.0–2.4) | 3 (3.7; 1.6–5.8) | |
| • Open the package without tearing the condom | 64 (79; 74.5–83.5) | 42 (51.2; 45.7–56.7) | 0.985 |
| • Do not use teeth to open the wrapper | 64 (79.0; 74.5–83.5) | 41 (50.0; 44.5–55.5) | |
| • Hold the condom by the last ½ inch at the tip, making sure to squeeze out any air | 31 (38.3; 32.9–43.7) | 19 (23.2; 18.5–27.9) | |
| • Put the condom on the tip of the thumb. | 61 (75.3; 70.5–80.1) | 38 (46.3; 40.8–51.8) | |
| • While still pinching the tip, unroll the condom down the shaft, to the base | 33 (40.4; 34.9–45.9) | 27 (32.9; 27.7–38.1) | |
| • Remove the condom by rolling it off | 51 (63.0; 57.6–68.4) | 31 (37.8; 32.4–43.2) | |
| • Throw the condom into the dustbin | 39 (48.1; 42.5–53.7) | 24 (29.3; 24.3–34.3) |
p value indicates the statistical significant difference in the proportion of interns and nurses regarding their skills.
Status of training of interns and nurses on family planning (FP) methods and services (as reported by the participants).
| Interns | Nurses | p-value | |
|---|---|---|---|
| • Attended a class on FP methods during training | 73 (90.1; 86.8–93.4) | 64 (78.0; 73.4–82.6) | 0.035 |
| • Ever Posted in FP clinic | 62 (76.5; 71.8–81.2) | 38 (46.3; 40.8–51.8) | 0 |
| • Observed counseling on different FP methods | 48 (59.3;53.8–64.8) | 57 (69.5; 64.4–74.6) | 0.172 |
| • Ever seen MEC wheel | 10 (12.3; 8.7–15.9) | 6 (7.3; 4.4–10.2) | 0.281 |
| • Ever observed MEC wheel used for a patient | 6 (7.4; 4.5–10.3) | 4 (4.9; 2.5–7.3) | 0.501 |
| • Observed IUCD insertion | 51 (63.0; 57.6–68.4) | 52 (63.4; 58.1–68.7) | 0.952 |
| • Performed IUCD insertion | 10 (12.3; 8.7–15.9) | 14 (17.1; 12.9–21.3) | 0.394 |
| • Inserted IUCD on dummy/ model | 9 (11.1; 7.6–14.6) | 11 (13.4; 9.6–17.2) | 0.645 |
| • Observed IUCD removal | 26 (32.1; 26.9–37.3) | 42 (51.2; 45.7–56.7) | 0.013 |
| • Performed IUCD removal | 16 (19.8; 15.4–24.2) | 23 (28.0; 23.0–33.0) | 0.215 |
| • Condom | 78 (96.3; 94.3–98.4) | 82 (100; 100–100) | 0.079 |
| • Oral Contraceptive Pill | 78 (96.3; 94.2–98.4) | 80 (97.6; 95.9–99.3) | 0.64 |
| • Intrauterine Device | 80 (98.8; 97.6–100) | 81 (98.8; 97.6–100) | 0.993 |
| • Depot medroxy progesterone acetate | 32 (39.5; 34.1–44.9) | 28 (34.1; 28.9–39.3) | 0.478 |
| • Emergency Contraceptive Pill | 64 (79.0; 74.5–83.4) | 63 (76.8; 72.1–81.5) | 0.737 |
| • Centchroman | 29 (35.8; 30.5–41.1) | 19 (23.2; 18.5–27.9) | 0.077 |
| • Hormonal IUCD | 38 (46.9; 41.4–52.3) | 9 (11.0; 7.5–14.5) | 0 |
| • Implantable Contraceptives | 10 (12.3; 8.7–15.9) | 13 (15.9; 11.9–19.9) | 0.52 |
| • Spermicides | 14 (17.3; 13,1–21.5) | 5 (6.1; 3.5–8.7) | 0.026 |
*MEC: Medical Eligibility Checklist; IUCD: Intrauterine contraceptive device; p value indicates the statistical significant difference in the proportion of interns and nurses